Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients
Physicians and scientists around the world are aggressively attempting to develop effective treatment strategies. The treatment goal is to reduce the fatality rate in 15% to 20% of individuals infected with SARS-CoV-2 who develop severe inflammatory conditions that can lead to pneumonia, and acute r...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-08-01
|
Series: | Journal of Biomedical Physics and Engineering |
Subjects: | |
Online Access: | https://jbpe.sums.ac.ir/article_46633_8cc1342d5ab6ca9c7fcdb0457485a667.pdf |
id |
doaj-21d5a8c82ee1455c8b276a022739dc1b |
---|---|
record_format |
Article |
spelling |
doaj-21d5a8c82ee1455c8b276a022739dc1b2020-11-25T03:21:33ZengShiraz University of Medical SciencesJournal of Biomedical Physics and Engineering2251-72002251-72002020-08-0110438739410.31661/jbpe.v0i0.2006-112546633Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 PatientsH Abdollahi0I Shiri1J J Bevelacqua2A Jafarzadeh3A Rahmim4H Zaidi5S A R Mortazavi6S M J Mortazavi7PhD, Department of Radiologic Sciences and Medical Physics, Faculty of Allied Medicine, Kerman University of Medical Science, Kerman, IranPhD, Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211 Geneva 4, SwitzerlandPhD, Bevelacqua Resources, Richland, Washington, United StatesPhD, Department of Immunology, School of Medicine, Kerman University of Medical Science, Kerman, IranPhD, Departments of Radiology and Physics, University of British Columbia, Vancouver BC, Canada |PhD, Department of Integrative Oncology, BC Cancer Research Centre, Vancouver BC, CanadaPhD, Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211 Geneva 4, Switzerland|PhD, Geneva University Neurocenter, Geneva University, Geneva, Switzerland|PhD, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands|PhD, Department of Nuclear Medicine, University of Southern Denmark, Odense, DenmarkMD, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranPhD, Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranPhysicians and scientists around the world are aggressively attempting to develop effective treatment strategies. The treatment goal is to reduce the fatality rate in 15% to 20% of individuals infected with SARS-CoV-2 who develop severe inflammatory conditions that can lead to pneumonia, and acute respiratory distress syndrome. These conditions are major causes of death in these patients. Convalescent plasma (CP) collected from patients recovered from the novel corona virus disease (COVID-19) has been considered as an effective treatment method for COVID-19. Moreover, low-dose radiation therapy (LDRT) for COVID-19 pneumonia was historically used to treat pneumonia during the first half of the 20th century. The concept of LDRT for COVID-19 pneumonia was first introduced in March 2020. Later scientists from Canada, Spain, United States, Germany and France also confirmed the potential efficacy of LDRT for treatment of COVID-19 pneumonia. The rationale behind introducing LDRT as an effective treatment method for pneumonia in COVID-19 patients is not only due to its anti-inflammatory effect, but also in optimization of the activity of the immune system. Moreover, LDRT, unlike other treatment methods such as antiviral drugs, does not have the key disadvantage of exerting a significant selective pressure on the SARS-CoV-2 virus and hence does not lead to evolution of the virus through mutations. Given these considerations, we believe that a hybrid treatment including both CP and LDRT can trigger synergistic responses that will help healthcare providers in mitigating today’s COVID-19 pandemic.https://jbpe.sums.ac.ir/article_46633_8cc1342d5ab6ca9c7fcdb0457485a667.pdflow dose radiationradiotherapycovid-19convalescent plasmaanti-inflammatory responsesimmune systemselective pressuremutations |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
H Abdollahi I Shiri J J Bevelacqua A Jafarzadeh A Rahmim H Zaidi S A R Mortazavi S M J Mortazavi |
spellingShingle |
H Abdollahi I Shiri J J Bevelacqua A Jafarzadeh A Rahmim H Zaidi S A R Mortazavi S M J Mortazavi Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients Journal of Biomedical Physics and Engineering low dose radiation radiotherapy covid-19 convalescent plasma anti-inflammatory responses immune system selective pressure mutations |
author_facet |
H Abdollahi I Shiri J J Bevelacqua A Jafarzadeh A Rahmim H Zaidi S A R Mortazavi S M J Mortazavi |
author_sort |
H Abdollahi |
title |
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients |
title_short |
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients |
title_full |
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients |
title_fullStr |
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients |
title_full_unstemmed |
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients |
title_sort |
low dose radiation therapy and convalescent plasma: how a hybrid method may maximize benefits for covid-19 patients |
publisher |
Shiraz University of Medical Sciences |
series |
Journal of Biomedical Physics and Engineering |
issn |
2251-7200 2251-7200 |
publishDate |
2020-08-01 |
description |
Physicians and scientists around the world are aggressively attempting to develop effective treatment strategies. The treatment goal is to reduce the fatality rate in 15% to 20% of individuals infected with SARS-CoV-2 who develop severe inflammatory conditions that can lead to pneumonia, and acute respiratory distress syndrome. These conditions are major causes of death in these patients. Convalescent plasma (CP) collected from patients recovered from the novel corona virus disease (COVID-19) has been considered as an effective treatment method for COVID-19. Moreover, low-dose radiation therapy (LDRT) for COVID-19 pneumonia was historically used to treat pneumonia during the first half of the 20th century. The concept of LDRT for COVID-19 pneumonia was first introduced in March 2020. Later scientists from Canada, Spain, United States, Germany and France also confirmed the potential efficacy of LDRT for treatment of COVID-19 pneumonia. The rationale behind introducing LDRT as an effective treatment method for pneumonia in COVID-19 patients is not only due to its anti-inflammatory effect, but also in optimization of the activity of the immune system. Moreover, LDRT, unlike other treatment methods such as antiviral drugs, does not have the key disadvantage of exerting a significant selective pressure on the SARS-CoV-2 virus and hence does not lead to evolution of the virus through mutations. Given these considerations, we believe that a hybrid treatment including both CP and LDRT can trigger synergistic responses that will help healthcare providers in mitigating today’s COVID-19 pandemic. |
topic |
low dose radiation radiotherapy covid-19 convalescent plasma anti-inflammatory responses immune system selective pressure mutations |
url |
https://jbpe.sums.ac.ir/article_46633_8cc1342d5ab6ca9c7fcdb0457485a667.pdf |
work_keys_str_mv |
AT habdollahi lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT ishiri lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT jjbevelacqua lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT ajafarzadeh lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT arahmim lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT hzaidi lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT sarmortazavi lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients AT smjmortazavi lowdoseradiationtherapyandconvalescentplasmahowahybridmethodmaymaximizebenefitsforcovid19patients |
_version_ |
1724613935320006656 |